Analysis of the expression profiles of these seven DEGs revealed that MAFG-DT, GPRIN1, and MYBL2 were highly expressed in the tumor group, and LINC00907, GSTZ1, CCN1, and GSTM5 were lowly expressed in the tumor group (Figure 2(d)). This evidence concerns the gene GPRIN1 and neoplasm.